Richard Buchta
Director/Board Member at BERONI GROUP LIMITED
Richard Buchta active positions
| Companies | Position | Start | End |
|---|---|---|---|
| BERONI GROUP LIMITED | Director/Board Member | 2020-06-30 | - |
| Independent Dir/Board Member | 2020-06-30 | - | |
Formulytica Pty Ltd.
 Formulytica Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Opal Biosciences Ltd., Formulytica Pty Ltd. is a specialty research organization that provides regulatory solutions, training in formulation and analytical techniques, and troubleshooting formulation and analytical methods. The company is based in Mulgrave, Australia. The Australian company specializes in contract formulation development services, analytical method development and validation, new product development, and the analytical science of semi-solid formulations. Formulytica was acquired by Opal Biosciences Ltd. on May 05, 2021. | Director/Board Member | - | - |
Opal Biosciences Ltd.
 Opal Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Opal Biosciences Ltd. develops antimicrobial and anti-infective products. The company was founded in and is headquartered in South Melbourne, Australia. | Director/Board Member | 2021-05-04 | - |
Career history of Richard Buchta
Former positions of Richard Buchta
| Companies | Position | Start | End |
|---|---|---|---|
Vyome Therapeutics, Inc.
 Vyome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vyome Therapeutics, Inc. develops research-based dermatology pharmaceutical solutions. It also develops drugs for antibiotics-resistant acne and other pathogens through a pipeline of antibiotics that retard resistance development. The company was founded by Rajesh Sudhir Gokhale, Rajeev Mantri, Venkateswarlu Nelabhotla, and Shiladitya Sengupta in August 2010 and is headquartered in Princeton, NJ. | Chief Tech/Sci/R&D Officer | 2014-11-30 | - |
Training of Richard Buchta
| Monash University | Undergraduate Degree |
| Deakin University | Masters Business Admin |
| Weizmann Institute of Science | Doctorate Degree |
| University of Trieste | Doctorate Degree |
Statistics
International
| Australia | 6 |
| Israel | 2 |
| Italy | 2 |
Operational
| Director/Board Member | 3 |
| Doctorate Degree | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoral
| Consumer Services | 5 |
| Health Technology | 4 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| BERONI GROUP LIMITED | Health Technology |
| Private companies | 3 |
|---|---|
Vyome Therapeutics, Inc.
Vyome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vyome Therapeutics, Inc. develops research-based dermatology pharmaceutical solutions. It also develops drugs for antibiotics-resistant acne and other pathogens through a pipeline of antibiotics that retard resistance development. The company was founded by Rajesh Sudhir Gokhale, Rajeev Mantri, Venkateswarlu Nelabhotla, and Shiladitya Sengupta in August 2010 and is headquartered in Princeton, NJ. | Health Technology |
Opal Biosciences Ltd.
Opal Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Opal Biosciences Ltd. develops antimicrobial and anti-infective products. The company was founded in and is headquartered in South Melbourne, Australia. | Health Technology |
Formulytica Pty Ltd.
Formulytica Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Opal Biosciences Ltd., Formulytica Pty Ltd. is a specialty research organization that provides regulatory solutions, training in formulation and analytical techniques, and troubleshooting formulation and analytical methods. The company is based in Mulgrave, Australia. The Australian company specializes in contract formulation development services, analytical method development and validation, new product development, and the analytical science of semi-solid formulations. Formulytica was acquired by Opal Biosciences Ltd. on May 05, 2021. | Commercial Services |
- Stock Market
- Insiders
- Richard Buchta
- Experience